Consolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and ...

Poherdy is the first FDA-approved interchangeable biosimilar to Perjeta for HER2-positive breast cancer, potentially expanding access and reducing costs. Approved for use in combination with ...

A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

As neural implant technology and A.I. advance at breakneck speeds, do we need a new set of rights to protect our most ...

Private certification, insurer evaluation and peer-reviewed research step up.

Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, ...

Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsMarDee Haring-Layton - Chief Accounting ...

FDA approves multiple denosumab biosimilars, enhancing market access and introducing interchangeability, boosting competition in bone health therapies.

A sponsor will have to demonstrate success with "with several consecutive patients with different bespoke therapies" to ...

The smart thermometer performs a check-up on your body temperature, cardiac, and pulmonary health in less than a minute.